Macular Degeneration (Pre Clinical Study)

Главная » Условия » Macular Degeneration (Pre Clinical Study)

Macular Degeneration (Pre Clinical Study)

Macular degeneration is a group of conditions that typically affect older adults, leading to the gradual loss of central vision. While there is currently no cure, there is still hope for slowing the progression of the disease. Eyetas is specially formulated to counteract photoreceptor damage by repairing and regenerating retinal cells.

Daily oral administration with a) omega-3 + omega-6 (100mg EPA +50 mg DHA +30 mg GLA) or b) omega-3 (130 mg EPA) for 3  months in 9-month-old CCL2-/- mice of retinal degeneration demonstrated significant protection of photoreceptors (i.e. increase of outer nuclear layer (ONL thickness) and reduced inflammatory markers at the gene and protein level in isolated retinas. Treatment groups showed reduced blood AA/EPA ratio below 2 and a significant increase in the retinal EPA.

Поддерживающее исследование

Red blood cell membrane and adipose tissue lipids were analysed as an indication of short-term and long-term dietary fatty acid in a family with autosomal dominant Stargatdt’s macular dystrophy. When adipose lipids were analysed, there was a significant inverse relationship between phenotypic severity and the level of eicosapentaenoic acid. When red blood cell lipids were analysed, there were significant inverse relationships between phenotypic severity and levels of eicosapentaenoic and docosahexanoic fatty acids.

The retinal outer nuclear layer is found reduced in patients with macular dystrophies. When mice models with Stargart’s disease were treated with Omega 3 the thickness of the retinal outer nuclear layer increased a considerable amount.

Visit Us

Contact Us

Eyetas 2024. All rights reserved © Copyrights |  Terms & Conditions  | Политика конфиденциальности

Designed by: LightBlack
ru_RURussian